+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

Exosome Isolation - Global Strategic Business Report - Product Thumbnail Image

Exosome Isolation - Global Strategic Business Report

  • Report
  • November 2026
  • 385 Pages
  • Global
From
From
m-RNA Synthesis Services - Global Strategic Business Report 2026 - Product Thumbnail Image

m-RNA Synthesis Services - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 227 Pages
  • Global
From
From
Sanger Sequencing - Global Strategic Business Report 2026 - Product Thumbnail Image

Sanger Sequencing - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 178 Pages
  • Global
From
From
DNA Amplification Kits - Global Strategic Business Report - Product Thumbnail Image

DNA Amplification Kits - Global Strategic Business Report

  • Report
  • November 2026
  • 272 Pages
  • Global
From
From
Flow Cytometry in Oncology - Global Strategic Business Report - Product Thumbnail Image

Flow Cytometry in Oncology - Global Strategic Business Report

  • Report
  • November 2026
  • 570 Pages
  • Global
From
From
Cell Transfection - Global Strategic Business Report - Product Thumbnail Image

Cell Transfection - Global Strategic Business Report

  • Report
  • November 2026
  • 294 Pages
  • Global
From
From
Airlift Bioreactors - Global Strategic Business Report - Product Thumbnail Image

Airlift Bioreactors - Global Strategic Business Report

  • Report
  • November 2026
  • 553 Pages
  • Global
From
Gene Delivery Technologies - Global Strategic Business Report - Product Thumbnail Image

Gene Delivery Technologies - Global Strategic Business Report

  • Report
  • November 2026
  • 370 Pages
  • Global
From
Glycomic Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Glycomic Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 401 Pages
  • Global
From
Digital Biomanufacturing - Global Strategic Business Report - Product Thumbnail Image

Digital Biomanufacturing - Global Strategic Business Report

  • Report
  • November 2026
  • 341 Pages
  • Global
From
RNAi Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

RNAi Drug Delivery - Global Strategic Business Report

  • Report
  • November 2026
  • 294 Pages
  • Global
From
Biomanufacturing - Global Strategic Business Report - Product Thumbnail Image

Biomanufacturing - Global Strategic Business Report

  • Report
  • November 2026
  • 375 Pages
  • Global
From
From
Bioproduction - Global Strategic Business Report - Product Thumbnail Image

Bioproduction - Global Strategic Business Report

  • Report
  • November 2026
  • 380 Pages
  • Global
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more